Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,236 | 458 | 96.9% |
| Education | $354.97 | 20 | 2.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $124.88 | 1 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,252 | 53 | $0 (2024) |
| Novo Nordisk Inc | $2,091 | 81 | $0 (2024) |
| Lilly USA, LLC | $1,645 | 72 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $1,401 | 62 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $992.32 | 20 | $0 (2021) |
| Amgen Inc. | $963.06 | 29 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $816.44 | 24 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $763.17 | 24 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $554.44 | 12 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $415.11 | 13 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,232 | 68 | Amgen Inc. ($624.17) |
| 2023 | $1,748 | 57 | Bayer Healthcare Pharmaceuticals Inc. ($414.88) |
| 2022 | $2,170 | 50 | AstraZeneca Pharmaceuticals LP ($723.70) |
| 2021 | $1,101 | 37 | Novo Nordisk Inc ($212.31) |
| 2020 | $494.34 | 20 | Amarin Pharma Inc. ($134.55) |
| 2019 | $2,045 | 66 | Novo Nordisk Inc ($383.20) |
| 2018 | $3,402 | 95 | Novo Nordisk Inc ($698.97) |
| 2017 | $2,523 | 86 | SANOFI-AVENTIS U.S. LLC ($780.05) |
All Payment Transactions
479 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $9.99 | General |
| Category: Diabetes | ||||||
| 12/02/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $9.38 | General |
| Category: Inflammation | ||||||
| 11/15/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $10.54 | General |
| Category: Inflammation | ||||||
| 11/02/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $30.46 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/28/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $10.24 | General |
| Category: Inflammation | ||||||
| 10/24/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $4.70 | General |
| Category: UROLOGY | ||||||
| 10/23/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $22.87 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/21/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $29.41 | General |
| Category: NEUROSCIENCE | ||||||
| 10/11/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $95.18 | General |
| Category: Endocrinology | ||||||
| 10/04/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $10.94 | General |
| Category: Inflammation | ||||||
| 09/26/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $11.09 | General |
| Category: Endocrinology | ||||||
| 09/12/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: NEUROSCIENCE | ||||||
| 09/05/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: Diabetes | ||||||
| 09/04/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $32.42 | General |
| Category: Endocrinology | ||||||
| 09/02/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: Diabetes | ||||||
| 08/30/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/29/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $124.54 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/28/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: VACCINES | ||||||
| 08/27/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $9.86 | General |
| Category: Inflammation | ||||||
| 08/19/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $9.75 | General |
| Category: Inflammation | ||||||
| 08/15/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $124.88 | General |
| Category: UROLOGY | ||||||
| 08/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/29/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $11.38 | General |
| Category: Inflammation | ||||||
| 07/26/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $27.42 | General |
| Category: Endocrinology | ||||||
About Dr. David Sanchez, MD
Dr. David Sanchez, MD is a General Practice healthcare provider based in Santa Ana, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/16/2007. The National Provider Identifier (NPI) number assigned to this provider is 1316162258.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Sanchez, MD has received a total of $15,716 in payments from pharmaceutical and medical device companies, with $2,232 received in 2024. These payments were reported across 479 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($15,236).
Practice Information
- Specialty General Practice
- Location Santa Ana, CA
- Active Since 04/16/2007
- Last Updated 11/22/2017
- Taxonomy Code 208D00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1316162258
Products in Payments
- FARXIGA (Drug) $1,272
- TRULICITY (Drug) $997.74
- JARDIANCE (Drug) $808.46
- SOLIQUA (Drug) $805.76
- Ozempic (Drug) $712.09
- CUVITRU (Biological) $517.64
- XARELTO (Drug) $499.15
- INVOKANA (Drug) $479.00
- VRAYLAR (Drug) $461.30
- Kerendia (Drug) $429.44
- ENTRESTO (Drug) $415.11
- Tresiba (Drug) $405.01
- Otezla (Drug) $371.80
- TOUJEO (Drug) $351.43
- MOUNJARO (Drug) $343.42
- Vascepa (Drug) $317.77
- NURTEC ODT (Drug) $316.67
- TRELEGY ELLIPTA (Drug) $247.50
- Victoza (Drug) $243.26
- Korlym (Drug) $216.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
General Practice Doctors in Santa Ana
Dr. Joseph Kim, D.d.s, D.D.S
General Practice — Payments: $49,752
Lucy Saenz, Md, MD
General Practice — Payments: $6,018
Linda Pearce, Dds, DDS
General Practice — Payments: $3,914
Mr. Viet Nghiem, Dds, DDS
General Practice — Payments: $3,039
Dr. Majid Kashani, D.d.s, D.D.S
General Practice — Payments: $2,664
Dr. Sepehr Saeedi, Dmd, DMD
General Practice — Payments: $2,360